Cardionovum

Be up
to date.

Latest press release

RESTORE clinical study results on in-stent restenosis.

Cardionovum experiences increase in demand for its innovative, and next generation „RESTORE Paclitaxel-releasing coronary balloon dilatation catheter.“ The American Journal of Cardiology, issue December 2015, published study results on the efficacy and safety of Paclitaxel coated balloon catheters for the treatment of in-stent restenosis in high risk patients. The RESTORE DEB showed significant superiority with lowest incidence of restenosis, if compared to other contemporary coronary DEBs.

Learn more >>

Cardionovum at LINC 2016

Dr. Jean Paul de Vries (PI) presented the patient study results of the multi-center randomized RAPID trial.

Learn more >>

Early APERTO patient results look promising.

Cardionovum prepares for a first international publication on 6-12 months FU patient results from the ongoing APERTO clinical study program. The APERTO Paclitaxel-releasing high pressure shunt balloon dilatation catheter was exclusively designed to treat shunt stenosis of hemodialysis patients.

Learn more >>

Upcoming events

Currently there are no events.

Latest events

Cardionovum at CIRSE annual meeting

Cardionovum participates at CIRSE meeting.

Date: Sep 16, 2017–Sep 21, 2017

Location: Copenhagen, Denmark

Visit website >>

Cardionovum at SCR’17

Cardionovum participates at the Swiss Congress of Radiology SCR’17 Bern.

Date: June 08, 2017–June 11, 2017

Location: Kursaal Bern, Switzerland

Learn more >>

Visit website >>

Cardionovum EuroPCR exclusive event

Cardionovum customers deserve the best.
Exclusive Cardionovum event at EuroPCR 2017.

Date: May 17, 2017–May 18, 2017

Location: Maison de l'amérique latine, Paris, France

Learn more >>

Visit website >>

go top